India revokes patent of Novartis' cardiac drug
Published on: Sept. 16, 2025, 1:53 a.m. | Source: Times of India
India Business News: NEW DELHI: The Indian Patent Office (IPO) has revoked the patent on Novartis' cardiac blockbuster drug Vymada on grounds of lack of novelty, potential.
